This contract expires in 324 days (Jun 11, 2027).
EPOCH CONCEPTS LLC - THIS IS A TASK ORDER FOR NUTANIX UPGRADE FOR MULTIPLE VISN SITES.
Key Details
Description
THIS IS A TASK ORDER FOR NUTANIX UPGRADE FOR MULTIPLE VISN SITES.
Context & Analysis
Department of Veterans Affairs obligated $7,808,327.84 to EPOCH CONCEPTS LLC for this is a task order for nutanix upgrade for multiple visn sites.. Performance is located in DC. The contract is scheduled through Jun 11, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Veterans Affairs — related awards are listed below.
Contractor Information
Similar Awards
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE THE DEPARTMENT OF VETERANS AFFAIRS WITH AN ENTERPRISE AGREEMENT FOR BRAND NAME MICROSOFT SOFTWARE PRODUCTS AND SERVICES. THIS ENTERPRISE AGREEMENT WILL PROVIDE 1) SUPPORT SERVICES 2) OPERATIONAL SUPPORT AND 3) ADDITIONAL LICENSES OF MICROSOFT PRODUCTS, CURRENT AND PLANNED, TO SUPPORT THE VA ENTERPRISE. SUBJECT PROCUREMENT WAS COMPETED AMONG MICROSOFT'S EIGHT AUTHORIZED FEDERAL GOVERNMENT LICENSE SOLUTION PROVIDERS. IGF::OT::IGF
DELL FEDERAL SYSTEMS L.P
$1.7B
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE THE DEPARTMENT OF VETERANS AFFAIRS WITH AN ENTERPRISE AGREEMENT FOR BRAND NAME MICROSOFT SOFTWARE PRODUCTS AND SERVICES. THIS ENTERPRISE AGREEMENT WILL PROVIDE 1) SUPPORT SERVICES 2) OPERATIONAL SUPPORT AND 3) ADDITIONAL LICENSES OF MICROSOFT PRODUCTS, CURRENT AND PLANNED, TO SUPPORT THE VA ENTERPRISE. SUBJECT PROCUREMENT WAS COMPETED AMONG MICROSOFT'S EIGHT AUTHORIZED FEDERAL GOVERNMENT LICENSE SOLUTION PROVIDERS. IGF::OT::IGF
DELL FEDERAL SYSTEMS L.P
$1.7B
IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES, TO INCLUDE HOSTING, FOR THE EHRM APPLICATIONS, APPLICATION SERVICES, AND ALL SUPPORTING EHRM DATA.
ORACLE HEALTH GOVERNMENT SERVICES, INC.
$1.5B
EHRM WAVES K, L, M (VISN 23) AND N, O (VISN 15) DEPLOYMENTS
ORACLE HEALTH GOVERNMENT SERVICES, INC.
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
Stay Updated
Get notified about new opportunities matching your interests.